By: Benzinga
November 29, 2012 at 10:39 AM EST
UPDATE: Compass Point Ugrades DR Horton to Neutral on Updated Forecasts
Compass Point raised its rating on DR Horton (NYSE: DHI ) from Sell to Neutral and raised its price target to $18.50. Compass Point commented, "After a full model update we are raising estimates and, coupled with the stock's relative underperformance in the post-QE3 trade, we now feel DHI should
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here